Clinical Trial Update: A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination regimens including JNJ-73763989 and JNJ-56136379 for chronic hepatitis B; the study is completed and results were posted on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• JNJ-56136379
• JNJ-73763989

Snippet

Sponsor: Janssen Sciences Ireland UC | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2024-07-10